FDA Import Refusal 799-0297731-2/11/1 — Aimil Pharmaceuticals India
The FDA refused shipment 799-0297731-2/11/1 from Aimil Pharmaceuticals India (India) on Feb 16, 2021. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Feb 16, 2021
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66VAY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 75